Trust Doctor (eqv to ST3) in Haemato-oncology | Barts Health NHS Trust
| Dyddiad hysbysebu: | 09 Mawrth 2026 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £50,175 - £67,610 per annum |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 08 Ebrill 2026 |
| Lleoliad: | London, EC1A 7BE |
| Cwmni: | Barts Health NHS Trust |
| Math o swydd: | Cytundeb |
| Cyfeirnod swydd: | 7857129/259-MED7857129SBH |
Crynodeb
Barts Health NHS Trust
Trust Doctor (eqv to ST3+) in Haemato-oncology
St Bartholomew’s Hospital
Full-time
Barts Health NHS Trust invites applicants for a ST3 equivalent/Trust doctor post in Haematology, based at St Bartholomew’s Hospital (SBH). This post is to cover a short term gap in the NE London Haematology and Oncology training rotations. This post is available from March 2026 and is for 6-12 months in the first instance. Full MRCP (or equivalent) is an essential requirement and your application will not be considered without it.
The post holder will work under the clinical direction of all the consultants in the respective Haematology or Haemato-Oncology Departments with a clearly identified clinical and educational supervisor. The post would be ideal for those wishing to pursue a career in Haematology and who subsequently wish to apply for a National Training Number. As such the post is suitable for experienced SHO equivalents/Clinical Fellows/Registrars who plan to pursue a career in Haematology and who would like to add to their experience in Haemato-oncology.
SBH is a busy and well supported level 3 Haemato-oncology unit an extensive Haematopioetic Stem Cell Transplant (HSCT) and CAR-T cell therapy programme. Clinical duties within the Haemato-oncology Department will cover the whole range of haematological malignancies, with the post-holder rotating between the inpatient and day-unit clinical areas while at SBH. The successful candidate will have clinical responsibility for patients admitted to the wards, those ambulatory patients seen on the Day unit and those seen in outpatients. Training and support to become proficient in bone marrow biopsy, intrathecal chemotherapy and chemotherapy prescribing will be provided, as will clinical trial experience and opportunities to take part in quality improvement / audit / research projects.
The post holder will be expected to prioritise and time-manage effectively according to the activity of the department and to utilise appropriately the available senior staff for advice. The Department has a key awareness of the importance of clinical audit, and all specialist trainees are encouraged to complete audit projects whilst here. Active participation in undergraduate and CMT teaching is also encouraged.
This post does not have educational approval from the postgraduate dean and will not be recognised for training, however support will be provided for career development. In-house SpR teaching and training sessions are currently running and attendance is encouraged
Barts Health is one of the largest NHS trusts in the country, and one of Britain’s leading healthcare providers.
The Barts Health group of NHS hospitals is entering an exciting new era on our improvement journey to becoming an outstanding organisation with a world-class clinical reputation. Having lifted ourselves out of special measures, we now have the impetus and breathing space to chart a fresh course in which we are continually striving to improve all our services for patients.
Our vision is to be a high-performing group of NHS hospitals, renowned for excellence and innovation, and providing safe and compassionate care to our patients in east London and beyond. That means being a provider of excellent patient safety, known for delivering consistently high standards of harm-free care and always caring for patients in the right place at the right time. It also means being an outstanding place to work, in which our WeCare values and behaviours are visible to all and guide us in how we work together.
We strive to live by our WeCare values and are committed to promoting inclusion, where every staff member has a sense of belonging. We value our differences and fully advocate, cultivate and support an inclusive working environment.
Share workload with other Ward SpRs in an equitable manner.
Assist the Day unit teams where possible for example clerking in ward emergency admissions on the
Day unit.
Assist the other firm by offering to take on practical procedures if there is an imbalance in activity.
Day to day management of haematology inpatients on the Barts site
Ensure a daily review of all patients and their results (including results endorsement) in conjunction with
SHO’s and liaison with the Attending consultant as indicated
Ensure all chemotherapy is prescribed and administered in a correct and timely fashion – liaise with
unit pharmacist as necessary.
Provide daily clinical review of CAR-T cell therapy and transplant patients and their blood results
including ciclosporin/tacrolimus levels and ensure the relevant medications are taken as required.
Write CAR-T / HSCT protocols for patients having cellular therapy procedures. Ensure these are
available for the Transplant meeting for discussion 1 week prior to admission (even if information still
outstanding).
Provide point of contact for Haematology referrals from other hospitals. This may include arranging
ward admission if necessary. To discuss them with Attending consultant
Communicate closely with Attending consultant, non-attending consultants, ward sisters, CNS’s and
Day Unit staff
Performing practical procedures as necessary and arrange staging investigation/MDM discussion
Discharge summaries, coding and communication with GP’s/referring consultants.
Ensure all new patients are presented at the next available MDM and follow up action points.
Handover each evening to the on-call SpR and to other ward SpR as necessary to ensure smooth
continuity of patient care
Attend Outpatient clinic as required and follow up tasks as necessary. Cancel clinic if absent giving at
least 6 weeks’ notice. Ensure timely production of letters within current Trust targets.
To strive to ensure that the Cancer Waiting Time targets are met (2 week, 31 day, 62 day).
Work with Research nurses as required on relevant commercial and NCRN trials. Ensure GCP training
up to date and SAEs are reported in a timely manner.
This advert closes on Sunday 22 Mar 2026